Keto Beats Mediterranean and Low-Fat Diets for Liver Health
By @sharedot · · 7 pages
- Health
- Nutrition
- Ketogenic Diet
- Fatty Liver Disease
A randomized WashU Medicine trial found a ketogenic diet cut liver fat by 67% and reversed prediabetes in half of participants, far outperforming other diets.
What Happened
A randomized clinical trial from Washington University School of Medicine in St. Louis, published August 27 in Cell Metabolism, compared three popular diets in adults with metabolically unhealthy obesity — obesity combined with prediabetes and fatty liver.
All food was provided and participants met weekly with a dietitian. Every group lost about 10% of starting body weight, and muscle insulin sensitivity improved roughly 50% across the board.
Why It's Surprising
The unexpected result is that diet composition mattered beyond weight loss alone.
Even though all groups shed identical weight, the ketogenic group's liver insulin sensitivity improved two to three times more than the other diets, and liver fat fell 67% versus about 45% on the Mediterranean and plant-forward plans.
Senior author Samuel Klein said weight loss on a very low-carbohydrate diet 'provides additional therapeutic effects on glucose and lipid metabolism' beyond weight loss itself.
First author Max C. Petersen noted the keto group avoided the downsides clinicians usually fear from high saturated fat intake.
The Evidence
Prediabetes remitted in 50% of the ketogenic group, 29% of the Mediterranean group, and 7% of the plant-forward group.
Fox News reports the keto diet derived about 4% of calories from carbohydrates and 73% from fat, and that dietitian Ilana Muhlstein said the findings show 'calories are not equal' because macronutrients drove different internal changes despite similar weight loss.
The Stakes
Fatty liver disease affects roughly 75% of adults with obesity worldwide and has become the fastest-growing cause of chronic liver disease and cirrhosis, according to Petersen.
Obesity affects about four in 10 Americans, most of whom face insulin resistance and liver fat buildup that can progress to Type 2 diabetes, chronic liver disease, and cardiovascular events.
With GLP-1 medicines now widely used for weight loss, Klein argued that 'diet composition should be considered part of the therapeutic strategy in treating people with obesity and concomitant prediabetes and liver disease,' making food choice relevant even alongside medication.
What Comes Next
The researchers caution the findings reflect strict adherence to prepared meals, not real-world recommendations, and the very restrictive diet — under 5% of energy from carbohydrates — may not translate to less severe low-carb approaches.
Petersen said many who try keto will not continue it long-term. Fox News reports dietitian Ilana Muhlstein recommends keto as a short-term option for people with prediabetes or fatty liver, then transitioning to a Mediterranean pattern for long-term heart and brain health.
Medscape notes outside experts including Duke's William Yancy Jr. want the diets tested alongside newer obesity medications such as GLP-1s.